The immunomodulatory effect of inhaled granulocyte-macrophage colony-stimulating factor in cystic fibrosis. A new treatment paradigm

BACKGROUND: Patients with cystic fibrosis (CF) experience recurrent infections and develop chronically infected lungs, which initiates an altered immunological alveolar environment. End-stage pulmonary dysfunction is a result of a long sequence of complex events in CF, progressing to alveolar macrop...

Descripción completa

Detalles Bibliográficos
Autores principales: Heslet, Lars, Bay, Christiane, Nepper-Christensen, Steen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278257/
https://www.ncbi.nlm.nih.gov/pubmed/22334793
http://dx.doi.org/10.2147/JIR.S22986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278257/
https://www.ncbi.nlm.nih.gov/pubmed/22334793
http://dx.doi.org/10.2147/JIR.S22986

Ejemplares similares